Meanwhile, the TMPRSS2: ERG fusion gene has been associated with prostate cancer and serves as a biomarker for the diagnosis and stratification of androgen-sensitive prostate cancer [26]. The gene discussed is TMPRSS2; the disease is prostate carcinoma.